Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Nebulized Ketamine in Preschoolers
NCT03885427Phase 1Completed
- Sponsor
- Zagazig University
- Start
- Mar 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine in pain and anxiety disorder (2 arms), sponsored by Zagazig University. Primary endpoints: Sedation Score (SS-5) at 30 minutes, Emotional State Score (ESS-4) at 30 minutes and 1 more. Started Mar 2019; status: completed.
02
Drugs
ketamine
03
Conditions
painanxiety disorder
Beyond the preview
Go deeper on NCT03885427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885427.